EMPLICITI elotuzumab 300mg lyophilized powder for IV infusion vial

Bristol-Myers Squibb Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: aa71ed8502ec84ea
Product Name: EMPLICITI elotuzumab 300mg lyophilized powder for IV infusion vial
Artg Id: 260052
Artg Name: EMPLICITI elotuzumab 300mg lyophilized powder for IV infusion vial
Sponsor: Bristol-Myers Squibb Australia Pty Ltd
Company Detail Path: /organization/bristol-myers-squibb-australia-pty-ltd
Artg Date: 2016-09-22
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/8dc318a4c2acc79de89f9be6333b45c4.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/58a3b5e6b9a0769ad2ffe8d29331ce7e.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

aa71ed8502ec84ea

Type

Standard